Assessment ofTakotsubo (ampulla) cardiomyopathy using99mTc-tetrofosmin myocardial SPECT —Comparison with acute coronary syndrome

We assessedTakotsubo (ampulla) cardiomyopathy compared with acute coronary syndrome (ACS) using two-dimensional echocardiography and^sup 99m^Tc-tetrofosmin myocardial SPECT.Methods: We examined 10 patients withTakotsubo cardiomyopathy and 16 with ACS at the time of emergency admission (acute phase), at three to nine days after the attack (subacute phase) and at one month after the attack (chronic phase). The left ventricle was divided into nine regions on echocardiograms and SPECT images, and the degree of abnormalities in each region was scored in five grades from normal (0) to severely abnormal (4).Results: Coronary angiography revealed total or subtotal occlusion in patients with ACS but no stenotic legions in those withTakotsubo cardiomyopathy. The amount of ST segment elevation (mm) was 7.9±3.4 in patients withTakotsubo cardiomyopathy and 7.3±3.7 in those with ACS (N.S.). Abnormal wall motion scores on echocardiograms were 13.8±4.4, 4.4±3.8 and 1.8±2.3 during the acute, subacute and chronic phases in patients withTakotsubo cardiomyopathy and 13.9±4.0, 11.7±3.7, 7.6±4.2, respectively in patients with ACS. The value of MB fraction of creatine phosphokinase (IU/l) was 34±23 in patients withTakotsubo cardiomyopathy and 326±98 in those with ACS (p